Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
Tariffs Impact Indian Pharma Firms, Threatening to Boost US Medical Costs
Recommend 12 Positive 21 Negative 15 |
||||
|
||||
|
The Trump administration is considering new tariffs on the pharmaceutical industry, prompting global drugmakers to increase output in the US, with generic drugmakers in India and other regions affected most significantly. The US imported US$246.8 billion of medicinal, dental and pharmaceutical products in 2024, Nikkei Asia quoted data from the US Department of Commerce as saying. The figure exceeded imports of passenger cars, accounting for 7.6% of total US imports. The increase in generic drug prices could lead to higher costs for US patients and insurers. AAStocks Financial News |
||||
Copied to Clipboard
 |
||||
